These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30353128)

  • 21. Inhibition of HSP90 overcomes melphalan resistance through downregulation of Src in multiple myeloma cells.
    Tabata M; Tsubaki M; Takeda T; Tateishi K; Maekawa S; Tsurushima K; Imano M; Satou T; Ishizaka T; Nishida S
    Clin Exp Med; 2020 Feb; 20(1):63-71. PubMed ID: 31650359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
    Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
    Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells.
    Belaiba RS; Bonello S; Zähringer C; Schmidt S; Hess J; Kietzmann T; Görlach A
    Mol Biol Cell; 2007 Dec; 18(12):4691-7. PubMed ID: 17898080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-1β upregulates Muc5ac expression via NF-κB-induced HIF-1α in asthma.
    Wu S; Li H; Yu L; Wang N; Li X; Chen W
    Immunol Lett; 2017 Dec; 192():20-26. PubMed ID: 29031476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.
    Kazi AA; Gilani RA; Schech AJ; Chumsri S; Sabnis G; Shah P; Goloubeva O; Kronsberg S; Brodie AH
    Breast Cancer Res; 2014 Jan; 16(1):R15. PubMed ID: 24472707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma.
    Tewari R; Choudhury SR; Ghosh S; Mehta VS; Sen E
    J Mol Med (Berl); 2012 Jan; 90(1):67-80. PubMed ID: 21887505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
    Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S
    Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Research on Relationship of HIF-1 Signaling Pathway and Postmenstrual Osteoporosis].
    Zhong H; Cao C; Yang J; Huang Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):862-868. PubMed ID: 29260521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RANKL-induced c-Src activation contributes to conventional anti-cancer drug resistance and dasatinib overcomes this resistance in RANK-expressing multiple myeloma cells.
    Mashimo K; Tsubaki M; Takeda T; Asano R; Jinushi M; Imano M; Satou T; Sakaguchi K; Nishida S
    Clin Exp Med; 2019 Feb; 19(1):133-141. PubMed ID: 30291461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells.
    Tsubaki M; Satou T; Itoh T; Imano M; Komai M; Nishinobo M; Yamashita M; Yanae M; Yamazoe Y; Nishida S
    Leuk Res; 2012 Oct; 36(10):1315-22. PubMed ID: 22819074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha.
    Shin DH; Li SH; Yang SW; Lee BL; Lee MK; Park JW
    FEBS J; 2009 Jul; 276(13):3470-80. PubMed ID: 19456861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypoxia/reoxygenation and lipopolysaccharide induced nuclear factor-ΚB and hypoxia-inducible factor-1α signaling pathways in intestinal epithelial cell injury and the interventional effect of emodin].
    Qi L; Yuan B; Fu Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jun; 26(6):409-14. PubMed ID: 24912640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells.
    Ren Z; Gu X; Lu B; Chen Y; Chen G; Feng J; Lin J; Zhang Y; Peng H
    J Cell Mol Med; 2016 Jun; 20(6):1095-105. PubMed ID: 26864945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro.
    Xi G; Hayes E; Lewis R; Ichi S; Mania-Farnell B; Shim K; Takao T; Allender E; Mayanil CS; Tomita T
    Oncogene; 2016 Jan; 35(2):241-50. PubMed ID: 25823028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
    Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
    Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
    Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells.
    Tabata M; Tsubaki M; Takeda T; Tateishi K; Tsurushima K; Imano M; Satou T; Ishizaka T; Nishida S
    BMC Complement Med Ther; 2020 Mar; 20(1):84. PubMed ID: 32171300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells.
    Wang F; Zhang W; Guo L; Bao W; Jin N; Liu R; Liu P; Wang Y; Guo Q; Chen B
    Cancer Sci; 2014 Aug; 105(8):1063-70. PubMed ID: 24890366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PJ34, a poly(ADP-ribose) polymerase (PARP) inhibitor, reverses melphalan-resistance and inhibits repair of DNA double-strand breaks by targeting the FA/BRCA pathway in multidrug resistant multiple myeloma cell line RPMI8226/R.
    Xiong T; Wei H; Chen X; Xiao H
    Int J Oncol; 2015 Jan; 46(1):223-32. PubMed ID: 25351371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AEG-1 Contributes to Metastasis in Hypoxia-Related Ovarian Cancer by Modulating the HIF-1alpha/NF-kappaB/VEGF Pathway.
    Yu X; Wang Y; Qiu H; Song H; Feng D; Jiang Y; Deng S; Meng H; Geng J
    Biomed Res Int; 2018; 2018():3145689. PubMed ID: 29770329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.